Rabies remains a significant global public health concern, causing an estimated 59,000–69,000 human fatalities annually. Despite being entirely preventable through vaccination, rabies continues to impose substantial economic burdens worldwide. This study presents a scoping review of the economic research on rabies to determine overlaps and gaps in knowledge and inform future research strategies. We selected 150 studies (1973–2024) to analyze. The review categorizes the literature based on geographic distribution, species focus, and type of study. Findings indicate that economic studies are disproportionately concentrated in developed countries, such as the United States and parts of Europe, where rabies risk is low, while high-risk regions, particularly in Africa and Asia, remain underrepresented. Most studies focus on dog-mediated rabies, reflecting its dominant role in human transmission, while fewer studies assess the economic impacts of wildlife and livestock-mediated rabies. Case studies and modeling approaches dominate the literature, whereas cost–benefit and cost–effectiveness analyses—critical for informing resource allocation—are limited. The review highlights the need for more economic evaluations in rabies-endemic regions, expanded research on non-dog reservoirs, and broader use of economic methods. Addressing these gaps will be crucial for optimizing rabies control and supporting global initiatives to eliminate dog-mediated rabies by 2030.
Rabies remains a significant global public health concern, causing an estimated 59,000-69,000 human fatalities annually. Despite being entirely preventable through vaccination, rabies continues to impose substantial economic burdens worldwide. This study presents a scoping review of the economic research of rabies to determine overlaps and gaps in knowledge and inform future research strategies. We selected 150 studies (1973-2024) to analyze. The review categorizes the literature based on geographic distribution, species focus, and type of study. Findings indicate that economic studies are disproportionately concentrated in developed countries, such as the United States and parts of Europe, where rabies risk is low, while high-risk regions, particularly in Africa and Asia, remain underrepresented. Most studies focus on dog-mediated rabies, reflecting its dominant role in human transmission, while fewer studies assess the economic impacts of wildlife and livestock-mediated rabies. Case studies and modeling approaches dominate the literature, whereas cost-benefit and cost-effectiveness analyses—critical for informing resource allocation—are limited. The review highlights the need for more economic evaluations in rabies-endemic regions, expanded research on non-dog reservoirs, and broader use of economic methods. Addressing these gaps will be crucial for optimizing rabies control and supporting global initiatives to eliminate dog-mediated rabies by 2030.
Wild pigs (Sus scrofa) have become a pervasive issue in the United States, causing significant damage to agricultural lands and ecosystems. Toxic baits have been developed as a potential management tool. This study evaluates the acceptability of toxic bait usage among U.S. crop producers and explores influential factors of respondent attitudes. Using data from a survey of crop producers in 11 states, we found that 59.6% of respondents somewhat or completely agreed that the use of a toxic bait in their state was acceptable, and 71.4% of respondents somewhat or completely agreed that they would be comfortable using toxic baits if they were experiencing a problem with wild pigs. Regression model results revealed that larger operations and producers of vulnerable crops were more likely to find use acceptable. Producers who generated income from wild pig hunting on their land tended to be less accepting, while those who generated income from the hunting of other species on their land tended to be more accepting. These findings suggest that the acceptability of a toxic bait is shaped by various economic, operational, and demographic factors but that there would likely be demand among producers of high-value crops facing a wild pig problem.
1 June 2024 in Journal of Zoo and Wildlife Medicine
Canine distemper virus (CDV) is a well-known RNA virus that affects domestic dogs and all families of wild terrestrial carnivores. Spillover infections from wildlife to domestic animals are mitigated by preventive vaccination, but there is limited information on the off-label use of veterinary vaccines for wildlife like raccoons (Procyon lotor). Twenty wild-caught raccoons were inoculated with a commercial recombinant DNA canarypox-vectored CDV vaccine, applying a regimen of two serial doses by SC route with an interval of 25-28 days between doses. The CDV serum virus neutralizing antibody (VNA) baseline titers and the postvaccination titers were measured at fixed time points. Forty percent (8/20) of the wild-caught raccoons had CDV VNA titers of 1:8 or greater upon intake, and all but a single individual were juvenile animals. Approximately one month following the first vaccine dose, 8% (1/12) of raccoons seronegative at baseline had serum CDV VNA titers of 1:24 or greater. Approximately one month following the booster vaccine dose, 67% (8/12) of raccoons seronegative at baseline had serum CDV VNA titers of 1:24 or greater. Among raccoons with CDV VNA titers greater than or equal to 1:8 at baseline, 13% (1/8) demonstrated a fourfold or greater rise in titer one month after the first vaccine dose, whereas 38% (3/8) reached the same threshold one month after the booster dose. The presence of naturally acquired CDV VNA in juvenile raccoons at the time of vaccination may have interfered with the humoral VNA response. A regimen of at least two serially administered SC vaccine doses may be immunogenic for raccoons, but further investigation of alternative routes, regimens, and CDV vaccine products is also warranted for this species.
5 October 2026 in The Journal of Wildlife Management
Biomarkers contribute to measuring uptake in wildlife baiting applications, such as oral rabies vaccination (ORV), when marking capabilities are adequately validated. One biomarker, iophenoxic acid (IPA), can exist in multiple analogues and has the potential of being a quantitative marker for ORV uptake, but the marking capabilities of the different analogues have not been adequately validated for target species, such as raccoons ( Procyon lotor ). We experimentally fed captive raccoons 4 different encapsulated IPA analogues, methyl, ethyl, butyl, and pentyl, at 3 different doses, 2.5 mg, 5 mg, and 10 mg, to evaluate marking and decay relative to dose. We then evaluated marking of 2 IPA analogues, ethyl and propyl, incorporated within the matrix of placebo ORV baits. We evaluated the concentration of each IPA analogue in raccoon serum using liquid chromatography tandem mass spectrometry. For marking and decay evaluation, all 4 IPAs at all doses marked raccoons beyond 454 days, and we observed dose‐dependent relationships with serum IPA concentration. Testing with ethyl or propyl in an ORV bait matrix at 1 mg IPA per bait marked raccoon sera for at least 67 days post‐consumption. All IPAs evaluated have use for estimating bait uptake by raccoons. The IPA analogue, sampling window, and dose are all factors to consider when selecting and using an IPA for estimating bait uptake in wildlife.